Form 8-K Guardant Health, Inc. For: Feb 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Guardant Health (GH) PT Lowered to $130 at Stifel
February 24, 2022 6:57 AM ESTStifel analyst Daniel Arias lowered the price target on Guardant Health (NASDAQ: GH) to $130.00 (from $160.00) while maintaining a Buy rating.
The analyst commented, "GH finished the year with a good beat and an initial 2022 outlook that includes solid clinical volume growth expectations... More
Guardant Health (GH) PT Lowered to $110 at Cowen
February 24, 2022 6:42 AM ESTCowen analyst Max Masucci lowered the price target on Guardant Health (NASDAQ: GH) to $110.00 (from $170.00) while maintaining an Outperform rating.
The analyst commented, "With the ECLIPSE trial readout expected in mid-2022, GH is approaching another landmark event for the field of cancer... More
